NCT01508897View on ClinicalTrials.gov

Comparison of Two Liraglutide Formulations in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

May 28, 2004

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions

DiabetesHealthy

Interventions

DRUG

liraglutide

Single dose administered as subcutaneous injection

DRUG

liraglutide

Single dose administered as subcutaneous injection

Trial Locations (1)

89231

Novo Nordisk Investigational Site, Neu-Ulm

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY

NCT01508897 - Comparison of Two Liraglutide Formulations in Healthy Volunteers | Biotech Hunter | Biotech Hunter